The structural basis for mTOR function

被引:51
作者
Baretic, Domagoj [1 ]
Williams, Roger L. [1 ]
机构
[1] MRC, Mol Biol Lab, Cambridge CB2 0QH, England
关键词
mTOR; PI3K; Rapamycin; 4E-BP1; S6K1; PIKK; PHOSPHOINOSITIDE; 3-KINASE; MAMMALIAN TARGET; BINDING PARTNER; PROTEIN-KINASE; RAPAMYCIN TOR; COMPLEX-I; GROWTH; RAPTOR; MECHANISM; PATHWAY;
D O I
10.1016/j.semcdb.2014.09.024
中图分类号
Q2 [细胞生物学];
学科分类号
071013 [干细胞生物学];
摘要
The phosphoinositide 3-kinase (PI3K) related protein kinases (PIKKs) are a family of protein kinases with a diverse range of vital cellular functions. Recent high-resolution crystal structures of the protein kinase mTOR suggest general architectural principles that are likely to be common to all of the PIKKs. Furthermore, the structures make clear the close relationship of the PIKKs to the PI3Ks. However, the structures also make clear the unique features of mTOR that enable its substrate specificity. The active site is deeply recessed and flanked by structural elements unique to the PIKKs, namely, the FRB domain, the LST8 binding element, and a C-terminal stretch of helices known as the FATC domain. The FRB has a conserved element in it that is part of a bipartite substrate recognition mechanism that is probably characteristic of all of the PIKKs. The FRB also binds the mTOR inhibitor rapamycin that has been referred to as an allosteric inhibitor, implying that this inhibitor is actually a competitive inhibitor of the protein substrate. This bipartite substrate-binding site also helps clarify how rapamycin can result in substratespecific inhibition. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:91 / 101
页数:11
相关论文
共 66 条
[1]
Structure of TOR and its complex with KOG1 [J].
Adami, Alessandra ;
Garcia-Alvarez, Begona ;
Arias-Palomo, Ernesto ;
Barford, David ;
Llorca, Oscar .
MOLECULAR CELL, 2007, 27 (03) :509-516
[2]
Kinetic and catalytic mechanisms of protein kinases [J].
Adams, JA .
CHEMICAL REVIEWS, 2001, 101 (08) :2271-2290
[3]
[Anonymous], 2003, CURR BIOL
[4]
Characterization of the FKBP•Rapamycin•FRB ternary complex [J].
Banaszynski, LA ;
Liu, CW ;
Wandless, TJ .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2005, 127 (13) :4715-4721
[5]
Where is mTOR and what is it doing there? [J].
Betz, Charles ;
Hall, Michael N. .
JOURNAL OF CELL BIOLOGY, 2013, 203 (04) :563-574
[6]
FAT: a novel domain in PIK-related kinases [J].
Bosotti, R ;
Isacchi, A ;
Sonnhammer, ELL .
TRENDS IN BIOCHEMICAL SCIENCES, 2000, 25 (05) :225-227
[7]
Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002 [J].
Brunn, GJ ;
Williams, J ;
Sabers, C ;
Wiederrecht, G ;
Lawrence, JC ;
Abraham, RT .
EMBO JOURNAL, 1996, 15 (19) :5256-5267
[8]
LST8 negatively regulates amino acid biosynthesis as a component of the TOR pathway [J].
Chen, EJ ;
Kaiser, CA .
JOURNAL OF CELL BIOLOGY, 2003, 161 (02) :333-347
[9]
Structure of the FKBP12-rapamycin complex interacting with the binding domain of human FRAP [J].
Choi, JW ;
Chen, J ;
Schreiber, SL ;
Clardy, J .
SCIENCE, 1996, 273 (5272) :239-242
[10]
Not all substrates are treated equally Implications for mTOR, rapamycin-resistance and cancer therapy [J].
Choo, Andrew Y. ;
Blenis, John .
CELL CYCLE, 2009, 8 (04) :567-572